Abstract |
Finasteride is standard medical treatment for androgenetic alopecia; however, no large studies with 5 years or more of follow up have been performed in Japan. The authors followed Japanese men with androgenetic alopecia treated with finasteride for 5 years to evaluate long-term treatment efficacy. Of 903 men treated with finasteride (1 mg/day), 801 patients were evaluated over 5 years by modified global photographic assessment. Although the proportion of improvement was high (99.4%), modified global photographic assessment scores after 5 years of treatment were lower in patients with more advanced disease as measured by the modified Norwood-Hamilton scale. After separating patients into "sufficient" and "insufficient" efficacy groups according to the modified global photographic assessment score after 5 years (scores ≥6 and <6, respectively), multivariate analysis showed that independent risk factors of insufficient efficacy were age at start of treatment of 40 years or more (P = 0.021) and classification on the modified Norwood-Hamilton scale (P < 0.001), whereas presence of stress at start of treatment was a negative predictor (P = 0.025). In conclusion, continuous finasteride treatment for 5 years improved androgenetic alopecia with sustained effect among Japanese. Younger age and less advanced disease at start of treatment were the key predictors of higher finasteride efficacy.
|
Authors | Toshihiro Yoshitake, Akira Takeda, Kensaku Ohki, Yuko Inoue, Takanori Yamawaki, Saori Otsuka, Minekatsu Akimoto, Mitsuru Nemoto, Yasuhito Shimakura, Akio Sato |
Journal | The Journal of dermatology
(J Dermatol)
Vol. 42
Issue 7
Pg. 735-8
(Jul 2015)
ISSN: 1346-8138 [Electronic] England |
PMID | 25903108
(Publication Type: Journal Article)
|
Copyright | © 2015 Japanese Dermatological Association. |
Chemical References |
- 5-alpha Reductase Inhibitors
- Finasteride
|
Topics |
- 5-alpha Reductase Inhibitors
(therapeutic use)
- Adult
- Age Factors
- Alopecia
(drug therapy)
- Finasteride
(therapeutic use)
- Humans
- Japan
- Male
- Middle Aged
- ROC Curve
- Severity of Illness Index
- Stress, Psychological
(complications)
- Time Factors
|